Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics

1999

Serhan, 2002, Endogenous chemical mediators in anti-inflammation and pro-resolution, Curr Med Chem, 1, 177

Nathan, 2002, Points of control in inflammation, Nature, 420, 846, 10.1038/nature01320

Samuelsson, 1987, Leukotrienes and lipoxins: structures, biosynthesis, and biological effects, Science, 237, 1171, 10.1126/science.2820055

Serhan, 2000, Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing, J Exp Med, 192, 1197, 10.1084/jem.192.8.1197

Serhan, 2002, Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals, J Exp Med, 196, 1025, 10.1084/jem.20020760

Levy, 1999, Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a “stop” signaling switch for aspirin-triggered lipoxin A4, FASEB J, 13, 903, 10.1096/fasebj.13.8.903

Levy, 1997, A role for polyisoprenyl phosphates in intracellular signaling, Nature, 389, 985, 10.1038/40180

Qiu, 2000, IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment, Proc Natl Acad Sci USA, 97, 4267, 10.1073/pnas.97.8.4267

Liaudet, 2002, Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury, Ann Surg, 235, 568, 10.1097/00000658-200204000-00016

Hasko, 2000, Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock, J Immunol, 164, 1013, 10.4049/jimmunol.164.2.1013

Krump, 1997, Suppression of leukotriene B4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils, J Exp Med, 186, 1401, 10.1084/jem.186.8.1401

Linden, 2001, Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection, Annu Rev Pharmacol Toxicol, 41, 775, 10.1146/annurev.pharmtox.41.1.775

Ohta, 2001, Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage, Nature, 414, 916, 10.1038/414916a

Pitzalis, 2002, Regulation of leukocyte-endothelial interactions by glucocorticoids, Ann N Y Acad Sci, 966, 108, 10.1111/j.1749-6632.2002.tb04208.x

Serhan, 1994, Lipoxin biosynthesis and its impact in inflammatory and vascular events, Biochim Biophys Acta, 1212, 1, 10.1016/0005-2760(94)90185-6

Marcus, 1995, Aspirin as prophylaxis against colorectal cancer, N Engl J Med, 333, 656, 10.1056/NEJM199509073331011

Vane, 1982, 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin, 181

Clària, 1995, Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions, Proc Natl Acad Sci USA, 92, 9475, 10.1073/pnas.92.21.9475

Schottelius, 2002, An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile, J Immunol, 169, 7063, 10.4049/jimmunol.169.12.7063

Serhan, 1995, Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils, Biochemistry, 34, 14609, 10.1021/bi00044a041

Cronstein, 1999, Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB, Proc Natl Acad Sci USA, 96, 6377, 10.1073/pnas.96.11.6377

Serhan, 1997, Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?, Prostaglandins, 53, 107, 10.1016/S0090-6980(97)00001-4

Levy, 2001, Lipid mediator class switching during acute inflammation: signals in resolution, Nat Immunol, 2, 612, 10.1038/89759

Samuelsson, 1982, From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes, 153

Levy, 1997, Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer, FASEB J, 11, 234, 10.1096/fasebj.11.4.9068612

Clish, 2000, Oxidoreductases in lipoxin A4 metabolic inactivation, J Biol Chem, 275, 25372, 10.1074/jbc.M002863200

Maddox, 1998, Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity, FASEB J, 12, 487, 10.1096/fasebj.12.6.487

Tong, 2000, Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells, Biochem Biophys Res Commun, 276, 77, 10.1006/bbrc.2000.3437

Cho, 2002, Thiazolidinediones as a novel class of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors, Arch Biochem Biophys, 405, 247, 10.1016/S0003-9861(02)00352-1

Clish, 2001, Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase, Biochem Biophys Res Commun, 288, 868, 10.1006/bbrc.2001.5841

Clish, 1999, Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo, Proc Natl Acad Sci USA, 96, 8247, 10.1073/pnas.96.14.8247

Munger, 1999, Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis, Proc Natl Acad Sci USA, 96, 13375, 10.1073/pnas.96.23.13375

Bandeira-Melo, 2000, Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia, J Immunol, 164, 1029, 10.4049/jimmunol.164.2.1029

Chiang, 1999, Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion, J Clin Invest, 104, 309, 10.1172/JCI7016

Aliberti, 2002, Parasite-induced lipoxin A(4) is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection, J Exp Med, 196, 1253, 10.1084/jem.20021183

Aliberti, 2002, Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity, Nat Immunol, 3, 76, 10.1038/ni745

Levy, 2002, Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4, Nat Med, 8, 1018, 10.1038/nm748

Chiang, 1998, Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA, J Pharmacol Exp Ther, 287, 779

Perretti, 2002, Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor, Nat Med, 8, 1296, 10.1038/nm786

Titos, 1999, Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A4 (ATL), Am J Physiol, 277, C870, 10.1152/ajpcell.1999.277.5.C870

Fiorucci, 2002, Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage, Gastroenterology, 123, 1598, 10.1053/gast.2002.36558

Pouliot, 2000, Lipoxin A4 analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease, Biochemistry, 39, 4761, 10.1021/bi992551b

Bonnans, 2002, Lipoxins are potential endogenous antiinflammatory mediators in asthma, Am J Respir Crit Care Med, 165, 1531, 10.1164/rccm.200201-053OC

Sanak, 2000, Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics, Eur Respir J, 16, 44, 10.1034/j.1399-3003.2000.16a08.x

Mitchell, 2002, Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo, J Am Soc Nephrol, 13, 2497, 10.1097/01.ASN.0000032417.73640.72

Chiang, 2003, Cloning and characterization of a novel rat lipoxin A4 receptor that is conserved in structure and function, Br J Pharmacol, 139, 89, 10.1038/sj.bjp.0705220

Leonard, 2002, 15-epi-16-(para-fluorophenoxy)-lipoxin A4-methyl ester, a synthetic analogue of 15-epi-lipoxin A4, is protective in experimental ischemic acute renal failure, J Am Soc Nephrol, 13, 1657, 10.1097/01.ASN.0000015795.74094.91

Fierro, 2002, Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A4 and lipoxin A4, J Pharmacol Exp Ther, 300, 385, 10.1124/jpet.300.2.385

Gewirtz, 2002, Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis, J Immunol, 168, 5260, 10.4049/jimmunol.168.10.5260

Gavins, 2003, Leukocyte anti-adhesive actions of annexin 1: ALXR and FPR related anti-inflammatory mechanisms, Blood, 101, 4140, 10.1182/blood-2002-11-3411

Jozsef, 2002, Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes, Proc Natl Acad Sci USA, 99, 13266, 10.1073/pnas.202296999

Filep, 1999, Anti-inflammatory actions of lipoxin A4 stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions, Blood, 94, 4132, 10.1182/blood.V94.12.4132

Godson, 2000, Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages, J Immunol, 164, 1663, 10.4049/jimmunol.164.4.1663

Bandeira-Melo, 2000, Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking, J Immunol, 164, 2267, 10.4049/jimmunol.164.5.2267

Sodin-Semrl, 2000, Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases, J Immunol, 164, 2660, 10.4049/jimmunol.164.5.2660

McMahon, 2000, Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells: differential activation of MAP kinases through distinct receptors, J Biol Chem, 275, 27566, 10.1074/jbc.M001015200

Planagumà, 2002, Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor α-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4, FASEB J, 16, 1937, 10.1096/fj.02-0224fje

Devchand, 2003, Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host-defense, FASEB J, 17, 652, 10.1096/fj.02-0770com

Gronert, 1998, Identification of a human enterocyte lipoxin A4 receptor that is regulated by IL-13 and IFN-γ and inhibits TNF-α-induced IL-8 release, J Exp Med, 187, 1285, 10.1084/jem.187.8.1285

Soyombo, 1994, Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine, Allergy, 49, 230, 10.1111/j.1398-9995.1994.tb02654.x

Chiang, 2000, Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation, J Exp Med, 191, 1197, 10.1084/jem.191.7.1197

Resnati, 2002, The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R, Proc Natl Acad Sci USA, 99, 1359, 10.1073/pnas.022652999

Le, 2002, Formyl-peptide receptors revisited, Trends Immunol, 23, 541, 10.1016/S1471-4906(02)02316-5

Maderna, 2002, Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases, Am J Pathol, 160, 2275, 10.1016/S0002-9440(10)61175-3

Qiu, 2001, Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils, FASEB J, 15, 2736, 10.1096/fj.01-0576fje

Canny, 2002, Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia, Proc Natl Acad Sci USA, 99, 3902, 10.1073/pnas.052533799

Gewirtz, 1998, Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs, J Clin Invest, 101, 1860, 10.1172/JCI1339

Maderna, 2000, Influence of lipoxin A(4) and other lipoxygenase-derived eicosanoids on tissue factor expression, Am J Physiol Cell Physiol, 279, C945, 10.1152/ajpcell.2000.279.4.C945

Serhan, 2000, The scent of a phagocyte: advances on leukotriene B4 receptors, J Exp Med, 192, F5, 10.1084/jem.192.3.F5

Hong, 2003, Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation, J Biol Chem, 278, 14677, 10.1074/jbc.M300218200

FitzGerald, 2001, The coxibs, selective inhibitors of cyclooxygenase-2, N Engl J Med, 345, 433, 10.1056/NEJM200108093450607